nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP2C8—Etoposide—muscle cancer	0.0131	0.471	CbGbCtD
Fenofibrate—CYP3A4—Vincristine—muscle cancer	0.00581	0.208	CbGbCtD
Fenofibrate—CYP3A4—Etoposide—muscle cancer	0.00532	0.191	CbGbCtD
Fenofibrate—CYP3A4—Doxorubicin—muscle cancer	0.00363	0.13	CbGbCtD
Fenofibrate—Anorexia—Vincristine—muscle cancer	0.00213	0.00219	CcSEcCtD
Fenofibrate—Eczema—Doxorubicin—muscle cancer	0.00213	0.00219	CcSEcCtD
Fenofibrate—Hypotension—Vincristine—muscle cancer	0.00209	0.00215	CcSEcCtD
Fenofibrate—Renal failure acute—Doxorubicin—muscle cancer	0.00207	0.00213	CcSEcCtD
Fenofibrate—Feeling abnormal—Dactinomycin—muscle cancer	0.00206	0.00212	CcSEcCtD
Fenofibrate—Ill-defined disorder—Etoposide—muscle cancer	0.00206	0.00212	CcSEcCtD
Fenofibrate—Anaemia—Etoposide—muscle cancer	0.00205	0.00211	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00205	0.0021	CcSEcCtD
Fenofibrate—Liver function test abnormal—Methotrexate—muscle cancer	0.00204	0.0021	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00204	0.00209	CcSEcCtD
Fenofibrate—Increased appetite—Doxorubicin—muscle cancer	0.00203	0.00209	CcSEcCtD
Fenofibrate—Insomnia—Vincristine—muscle cancer	0.00202	0.00208	CcSEcCtD
Fenofibrate—Renal impairment—Doxorubicin—muscle cancer	0.00201	0.00206	CcSEcCtD
Fenofibrate—Paraesthesia—Vincristine—muscle cancer	0.00201	0.00206	CcSEcCtD
Fenofibrate—Malaise—Etoposide—muscle cancer	0.002	0.00206	CcSEcCtD
Fenofibrate—Dermatitis bullous—Doxorubicin—muscle cancer	0.002	0.00206	CcSEcCtD
Fenofibrate—Vertigo—Etoposide—muscle cancer	0.00199	0.00205	CcSEcCtD
Fenofibrate—Leukopenia—Etoposide—muscle cancer	0.00199	0.00204	CcSEcCtD
Fenofibrate—Abdominal pain—Dactinomycin—muscle cancer	0.00198	0.00203	CcSEcCtD
Fenofibrate—Body temperature increased—Dactinomycin—muscle cancer	0.00198	0.00203	CcSEcCtD
Fenofibrate—Hypoglycaemia—Doxorubicin—muscle cancer	0.00196	0.00201	CcSEcCtD
Fenofibrate—Decreased appetite—Vincristine—muscle cancer	0.00194	0.002	CcSEcCtD
Fenofibrate—Cough—Etoposide—muscle cancer	0.00194	0.00199	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Vincristine—muscle cancer	0.00193	0.00198	CcSEcCtD
Fenofibrate—Fatigue—Vincristine—muscle cancer	0.00193	0.00198	CcSEcCtD
Fenofibrate—Hypertension—Etoposide—muscle cancer	0.00191	0.00197	CcSEcCtD
Fenofibrate—Pain—Vincristine—muscle cancer	0.00191	0.00197	CcSEcCtD
Fenofibrate—Constipation—Vincristine—muscle cancer	0.00191	0.00197	CcSEcCtD
Fenofibrate—Osteoarthritis—Doxorubicin—muscle cancer	0.00191	0.00197	CcSEcCtD
Fenofibrate—Pain in extremity—Doxorubicin—muscle cancer	0.00191	0.00197	CcSEcCtD
Fenofibrate—Asthma—Methotrexate—muscle cancer	0.00191	0.00196	CcSEcCtD
Fenofibrate—Chest pain—Etoposide—muscle cancer	0.00189	0.00194	CcSEcCtD
Fenofibrate—Eosinophilia—Methotrexate—muscle cancer	0.00189	0.00194	CcSEcCtD
Fenofibrate—Migraine—Doxorubicin—muscle cancer	0.00188	0.00193	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00188	0.00193	CcSEcCtD
Fenofibrate—Pancreatitis—Methotrexate—muscle cancer	0.00187	0.00192	CcSEcCtD
Fenofibrate—Discomfort—Etoposide—muscle cancer	0.00187	0.00192	CcSEcCtD
Fenofibrate—Hypersensitivity—Dactinomycin—muscle cancer	0.00184	0.0019	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Vincristine—muscle cancer	0.00183	0.00188	CcSEcCtD
Fenofibrate—Infection—Etoposide—muscle cancer	0.0018	0.00185	CcSEcCtD
Fenofibrate—Asthenia—Dactinomycin—muscle cancer	0.00179	0.00185	CcSEcCtD
Fenofibrate—Blood creatinine increased—Doxorubicin—muscle cancer	0.00179	0.00184	CcSEcCtD
Fenofibrate—Dysuria—Methotrexate—muscle cancer	0.00178	0.00183	CcSEcCtD
Fenofibrate—Thrombocytopenia—Etoposide—muscle cancer	0.00177	0.00182	CcSEcCtD
Fenofibrate—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00177	0.00182	CcSEcCtD
Fenofibrate—Tachycardia—Etoposide—muscle cancer	0.00177	0.00182	CcSEcCtD
Fenofibrate—Abdominal pain—Vincristine—muscle cancer	0.00177	0.00182	CcSEcCtD
Fenofibrate—Body temperature increased—Vincristine—muscle cancer	0.00177	0.00182	CcSEcCtD
Fenofibrate—Liver function test abnormal—Doxorubicin—muscle cancer	0.00176	0.00181	CcSEcCtD
Fenofibrate—Skin disorder—Etoposide—muscle cancer	0.00176	0.00181	CcSEcCtD
Fenofibrate—Erectile dysfunction—Methotrexate—muscle cancer	0.00176	0.00181	CcSEcCtD
Fenofibrate—Hyperhidrosis—Etoposide—muscle cancer	0.00175	0.0018	CcSEcCtD
Fenofibrate—Photosensitivity reaction—Methotrexate—muscle cancer	0.00174	0.00179	CcSEcCtD
Fenofibrate—Anorexia—Etoposide—muscle cancer	0.00173	0.00177	CcSEcCtD
Fenofibrate—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00172	0.00177	CcSEcCtD
Fenofibrate—Diarrhoea—Dactinomycin—muscle cancer	0.00171	0.00176	CcSEcCtD
Fenofibrate—Pneumonia—Methotrexate—muscle cancer	0.00171	0.00176	CcSEcCtD
Fenofibrate—Nasopharyngitis—Doxorubicin—muscle cancer	0.00171	0.00176	CcSEcCtD
Fenofibrate—Infestation—Methotrexate—muscle cancer	0.0017	0.00175	CcSEcCtD
Fenofibrate—Infestation NOS—Methotrexate—muscle cancer	0.0017	0.00175	CcSEcCtD
Fenofibrate—Hypotension—Etoposide—muscle cancer	0.00169	0.00174	CcSEcCtD
Fenofibrate—Gastritis—Doxorubicin—muscle cancer	0.00169	0.00174	CcSEcCtD
Fenofibrate—Muscular weakness—Doxorubicin—muscle cancer	0.00168	0.00173	CcSEcCtD
Fenofibrate—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00168	0.00173	CcSEcCtD
Fenofibrate—Renal failure—Methotrexate—muscle cancer	0.00167	0.00172	CcSEcCtD
Fenofibrate—Conjunctivitis—Methotrexate—muscle cancer	0.00165	0.0017	CcSEcCtD
Fenofibrate—Asthma—Doxorubicin—muscle cancer	0.00165	0.0017	CcSEcCtD
Fenofibrate—Influenza—Doxorubicin—muscle cancer	0.00165	0.0017	CcSEcCtD
Fenofibrate—Hypersensitivity—Vincristine—muscle cancer	0.00165	0.00169	CcSEcCtD
Fenofibrate—Eosinophilia—Doxorubicin—muscle cancer	0.00163	0.00168	CcSEcCtD
Fenofibrate—Sweating—Methotrexate—muscle cancer	0.00163	0.00168	CcSEcCtD
Fenofibrate—Paraesthesia—Etoposide—muscle cancer	0.00163	0.00167	CcSEcCtD
Fenofibrate—Pancreatitis—Doxorubicin—muscle cancer	0.00162	0.00167	CcSEcCtD
Fenofibrate—Dyspnoea—Etoposide—muscle cancer	0.00161	0.00166	CcSEcCtD
Fenofibrate—Somnolence—Etoposide—muscle cancer	0.00161	0.00166	CcSEcCtD
Fenofibrate—Angina pectoris—Doxorubicin—muscle cancer	0.00161	0.00165	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Methotrexate—muscle cancer	0.00161	0.00165	CcSEcCtD
Fenofibrate—Asthenia—Vincristine—muscle cancer	0.0016	0.00165	CcSEcCtD
Fenofibrate—Vomiting—Dactinomycin—muscle cancer	0.00159	0.00164	CcSEcCtD
Fenofibrate—Bronchitis—Doxorubicin—muscle cancer	0.00159	0.00163	CcSEcCtD
Fenofibrate—Rash—Dactinomycin—muscle cancer	0.00158	0.00162	CcSEcCtD
Fenofibrate—Decreased appetite—Etoposide—muscle cancer	0.00157	0.00162	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Etoposide—muscle cancer	0.00156	0.00161	CcSEcCtD
Fenofibrate—Fatigue—Etoposide—muscle cancer	0.00156	0.00161	CcSEcCtD
Fenofibrate—Pain—Etoposide—muscle cancer	0.00155	0.00159	CcSEcCtD
Fenofibrate—Constipation—Etoposide—muscle cancer	0.00155	0.00159	CcSEcCtD
Fenofibrate—Dysuria—Doxorubicin—muscle cancer	0.00154	0.00159	CcSEcCtD
Fenofibrate—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00153	0.00158	CcSEcCtD
Fenofibrate—Diarrhoea—Vincristine—muscle cancer	0.00153	0.00157	CcSEcCtD
Fenofibrate—Hepatitis—Methotrexate—muscle cancer	0.00153	0.00157	CcSEcCtD
Fenofibrate—Pollakiuria—Doxorubicin—muscle cancer	0.00153	0.00157	CcSEcCtD
Fenofibrate—Pharyngitis—Methotrexate—muscle cancer	0.00151	0.00156	CcSEcCtD
Fenofibrate—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00151	0.00155	CcSEcCtD
Fenofibrate—Weight increased—Doxorubicin—muscle cancer	0.0015	0.00155	CcSEcCtD
Fenofibrate—Weight decreased—Doxorubicin—muscle cancer	0.00149	0.00154	CcSEcCtD
Fenofibrate—Feeling abnormal—Etoposide—muscle cancer	0.00149	0.00153	CcSEcCtD
Fenofibrate—Nausea—Dactinomycin—muscle cancer	0.00149	0.00153	CcSEcCtD
Fenofibrate—Pneumonia—Doxorubicin—muscle cancer	0.00148	0.00152	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Etoposide—muscle cancer	0.00148	0.00152	CcSEcCtD
Fenofibrate—Dizziness—Vincristine—muscle cancer	0.00148	0.00152	CcSEcCtD
Fenofibrate—Infestation NOS—Doxorubicin—muscle cancer	0.00147	0.00151	CcSEcCtD
Fenofibrate—Infestation—Doxorubicin—muscle cancer	0.00147	0.00151	CcSEcCtD
Fenofibrate—Visual impairment—Methotrexate—muscle cancer	0.00147	0.00151	CcSEcCtD
Fenofibrate—Renal failure—Doxorubicin—muscle cancer	0.00145	0.00149	CcSEcCtD
Fenofibrate—Urticaria—Etoposide—muscle cancer	0.00144	0.00148	CcSEcCtD
Fenofibrate—Jaundice—Doxorubicin—muscle cancer	0.00143	0.00148	CcSEcCtD
Fenofibrate—Abdominal pain—Etoposide—muscle cancer	0.00143	0.00147	CcSEcCtD
Fenofibrate—Body temperature increased—Etoposide—muscle cancer	0.00143	0.00147	CcSEcCtD
Fenofibrate—Conjunctivitis—Doxorubicin—muscle cancer	0.00143	0.00147	CcSEcCtD
Fenofibrate—Urinary tract infection—Doxorubicin—muscle cancer	0.00143	0.00147	CcSEcCtD
Fenofibrate—Eye disorder—Methotrexate—muscle cancer	0.00143	0.00147	CcSEcCtD
Fenofibrate—Vomiting—Vincristine—muscle cancer	0.00142	0.00146	CcSEcCtD
Fenofibrate—Cardiac disorder—Methotrexate—muscle cancer	0.00142	0.00146	CcSEcCtD
Fenofibrate—Sweating—Doxorubicin—muscle cancer	0.00141	0.00145	CcSEcCtD
Fenofibrate—Rash—Vincristine—muscle cancer	0.00141	0.00145	CcSEcCtD
Fenofibrate—Dermatitis—Vincristine—muscle cancer	0.00141	0.00145	CcSEcCtD
Fenofibrate—Headache—Vincristine—muscle cancer	0.0014	0.00144	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00139	0.00143	CcSEcCtD
Fenofibrate—Angiopathy—Methotrexate—muscle cancer	0.00138	0.00142	CcSEcCtD
Fenofibrate—Sinusitis—Doxorubicin—muscle cancer	0.00138	0.00142	CcSEcCtD
Fenofibrate—Mediastinal disorder—Methotrexate—muscle cancer	0.00138	0.00141	CcSEcCtD
Fenofibrate—Alopecia—Methotrexate—muscle cancer	0.00135	0.00139	CcSEcCtD
Fenofibrate—Mental disorder—Methotrexate—muscle cancer	0.00134	0.00138	CcSEcCtD
Fenofibrate—Hypersensitivity—Etoposide—muscle cancer	0.00133	0.00137	CcSEcCtD
Fenofibrate—Malnutrition—Methotrexate—muscle cancer	0.00133	0.00137	CcSEcCtD
Fenofibrate—Erythema—Methotrexate—muscle cancer	0.00133	0.00137	CcSEcCtD
Fenofibrate—Nausea—Vincristine—muscle cancer	0.00133	0.00137	CcSEcCtD
Fenofibrate—Rhinitis—Doxorubicin—muscle cancer	0.00132	0.00136	CcSEcCtD
Fenofibrate—Hepatitis—Doxorubicin—muscle cancer	0.00132	0.00136	CcSEcCtD
Fenofibrate—Pharyngitis—Doxorubicin—muscle cancer	0.00131	0.00135	CcSEcCtD
Fenofibrate—Oedema peripheral—Doxorubicin—muscle cancer	0.0013	0.00134	CcSEcCtD
Fenofibrate—Asthenia—Etoposide—muscle cancer	0.0013	0.00134	CcSEcCtD
Fenofibrate—Connective tissue disorder—Doxorubicin—muscle cancer	0.0013	0.00134	CcSEcCtD
Fenofibrate—Back pain—Methotrexate—muscle cancer	0.00129	0.00132	CcSEcCtD
Fenofibrate—Pruritus—Etoposide—muscle cancer	0.00128	0.00132	CcSEcCtD
Fenofibrate—Visual impairment—Doxorubicin—muscle cancer	0.00127	0.00131	CcSEcCtD
Fenofibrate—Diarrhoea—Etoposide—muscle cancer	0.00124	0.00127	CcSEcCtD
Fenofibrate—Eye disorder—Doxorubicin—muscle cancer	0.00123	0.00127	CcSEcCtD
Fenofibrate—Ill-defined disorder—Methotrexate—muscle cancer	0.00123	0.00127	CcSEcCtD
Fenofibrate—Anaemia—Methotrexate—muscle cancer	0.00123	0.00126	CcSEcCtD
Fenofibrate—Cardiac disorder—Doxorubicin—muscle cancer	0.00123	0.00126	CcSEcCtD
Fenofibrate—Angiopathy—Doxorubicin—muscle cancer	0.0012	0.00123	CcSEcCtD
Fenofibrate—Malaise—Methotrexate—muscle cancer	0.0012	0.00123	CcSEcCtD
Fenofibrate—Dizziness—Etoposide—muscle cancer	0.0012	0.00123	CcSEcCtD
Fenofibrate—Vertigo—Methotrexate—muscle cancer	0.00119	0.00123	CcSEcCtD
Fenofibrate—Mediastinal disorder—Doxorubicin—muscle cancer	0.00119	0.00123	CcSEcCtD
Fenofibrate—Leukopenia—Methotrexate—muscle cancer	0.00119	0.00122	CcSEcCtD
Fenofibrate—Arrhythmia—Doxorubicin—muscle cancer	0.00118	0.00121	CcSEcCtD
Fenofibrate—Alopecia—Doxorubicin—muscle cancer	0.00117	0.0012	CcSEcCtD
Fenofibrate—Cough—Methotrexate—muscle cancer	0.00116	0.00119	CcSEcCtD
Fenofibrate—Mental disorder—Doxorubicin—muscle cancer	0.00116	0.00119	CcSEcCtD
Fenofibrate—Vomiting—Etoposide—muscle cancer	0.00115	0.00118	CcSEcCtD
Fenofibrate—Malnutrition—Doxorubicin—muscle cancer	0.00115	0.00118	CcSEcCtD
Fenofibrate—Erythema—Doxorubicin—muscle cancer	0.00115	0.00118	CcSEcCtD
Fenofibrate—Rash—Etoposide—muscle cancer	0.00114	0.00117	CcSEcCtD
Fenofibrate—Dermatitis—Etoposide—muscle cancer	0.00114	0.00117	CcSEcCtD
Fenofibrate—Headache—Etoposide—muscle cancer	0.00113	0.00117	CcSEcCtD
Fenofibrate—Flatulence—Doxorubicin—muscle cancer	0.00113	0.00117	CcSEcCtD
Fenofibrate—Arthralgia—Methotrexate—muscle cancer	0.00113	0.00116	CcSEcCtD
Fenofibrate—Chest pain—Methotrexate—muscle cancer	0.00113	0.00116	CcSEcCtD
Fenofibrate—Myalgia—Methotrexate—muscle cancer	0.00113	0.00116	CcSEcCtD
Fenofibrate—Tension—Doxorubicin—muscle cancer	0.00113	0.00116	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00112	0.00116	CcSEcCtD
Fenofibrate—Discomfort—Methotrexate—muscle cancer	0.00112	0.00115	CcSEcCtD
Fenofibrate—Nervousness—Doxorubicin—muscle cancer	0.00112	0.00115	CcSEcCtD
Fenofibrate—Back pain—Doxorubicin—muscle cancer	0.00111	0.00114	CcSEcCtD
Fenofibrate—Muscle spasms—Doxorubicin—muscle cancer	0.00111	0.00114	CcSEcCtD
Fenofibrate—Infection—Methotrexate—muscle cancer	0.00108	0.00111	CcSEcCtD
Fenofibrate—Nausea—Etoposide—muscle cancer	0.00108	0.00111	CcSEcCtD
Fenofibrate—Ill-defined disorder—Doxorubicin—muscle cancer	0.00107	0.0011	CcSEcCtD
Fenofibrate—Nervous system disorder—Methotrexate—muscle cancer	0.00106	0.00109	CcSEcCtD
Fenofibrate—Anaemia—Doxorubicin—muscle cancer	0.00106	0.00109	CcSEcCtD
Fenofibrate—Thrombocytopenia—Methotrexate—muscle cancer	0.00106	0.00109	CcSEcCtD
Fenofibrate—Skin disorder—Methotrexate—muscle cancer	0.00105	0.00108	CcSEcCtD
Fenofibrate—Hyperhidrosis—Methotrexate—muscle cancer	0.00105	0.00108	CcSEcCtD
Fenofibrate—Malaise—Doxorubicin—muscle cancer	0.00104	0.00107	CcSEcCtD
Fenofibrate—Vertigo—Doxorubicin—muscle cancer	0.00103	0.00106	CcSEcCtD
Fenofibrate—Anorexia—Methotrexate—muscle cancer	0.00103	0.00106	CcSEcCtD
Fenofibrate—Leukopenia—Doxorubicin—muscle cancer	0.00103	0.00106	CcSEcCtD
Fenofibrate—Palpitations—Doxorubicin—muscle cancer	0.00102	0.00105	CcSEcCtD
Fenofibrate—Hypotension—Methotrexate—muscle cancer	0.00101	0.00104	CcSEcCtD
Fenofibrate—Cough—Doxorubicin—muscle cancer	0.001	0.00103	CcSEcCtD
Fenofibrate—Hypertension—Doxorubicin—muscle cancer	0.000993	0.00102	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000988	0.00102	CcSEcCtD
Fenofibrate—Insomnia—Methotrexate—muscle cancer	0.000981	0.00101	CcSEcCtD
Fenofibrate—Arthralgia—Doxorubicin—muscle cancer	0.000979	0.00101	CcSEcCtD
Fenofibrate—Chest pain—Doxorubicin—muscle cancer	0.000979	0.00101	CcSEcCtD
Fenofibrate—Myalgia—Doxorubicin—muscle cancer	0.000979	0.00101	CcSEcCtD
Fenofibrate—Anxiety—Doxorubicin—muscle cancer	0.000976	0.001	CcSEcCtD
Fenofibrate—Paraesthesia—Methotrexate—muscle cancer	0.000974	0.001	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000973	0.001	CcSEcCtD
Fenofibrate—Discomfort—Doxorubicin—muscle cancer	0.000968	0.000995	CcSEcCtD
Fenofibrate—Dyspnoea—Methotrexate—muscle cancer	0.000967	0.000994	CcSEcCtD
Fenofibrate—Somnolence—Methotrexate—muscle cancer	0.000964	0.000992	CcSEcCtD
Fenofibrate—Dry mouth—Doxorubicin—muscle cancer	0.000958	0.000985	CcSEcCtD
Fenofibrate—Dyspepsia—Methotrexate—muscle cancer	0.000954	0.000982	CcSEcCtD
Fenofibrate—Decreased appetite—Methotrexate—muscle cancer	0.000943	0.00097	CcSEcCtD
Fenofibrate—Oedema—Doxorubicin—muscle cancer	0.000939	0.000966	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000936	0.000963	CcSEcCtD
Fenofibrate—Fatigue—Methotrexate—muscle cancer	0.000935	0.000962	CcSEcCtD
Fenofibrate—Infection—Doxorubicin—muscle cancer	0.000933	0.000959	CcSEcCtD
Fenofibrate—Pain—Methotrexate—muscle cancer	0.000927	0.000954	CcSEcCtD
Fenofibrate—Nervous system disorder—Doxorubicin—muscle cancer	0.000921	0.000947	CcSEcCtD
Fenofibrate—Thrombocytopenia—Doxorubicin—muscle cancer	0.000919	0.000946	CcSEcCtD
Fenofibrate—Tachycardia—Doxorubicin—muscle cancer	0.000916	0.000943	CcSEcCtD
Fenofibrate—Skin disorder—Doxorubicin—muscle cancer	0.000912	0.000938	CcSEcCtD
Fenofibrate—Hyperhidrosis—Doxorubicin—muscle cancer	0.000908	0.000934	CcSEcCtD
Fenofibrate—Anorexia—Doxorubicin—muscle cancer	0.000895	0.000921	CcSEcCtD
Fenofibrate—Feeling abnormal—Methotrexate—muscle cancer	0.000893	0.000919	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Methotrexate—muscle cancer	0.000887	0.000912	CcSEcCtD
Fenofibrate—Hypotension—Doxorubicin—muscle cancer	0.000877	0.000902	CcSEcCtD
Fenofibrate—Urticaria—Methotrexate—muscle cancer	0.000861	0.000886	CcSEcCtD
Fenofibrate—Abdominal pain—Methotrexate—muscle cancer	0.000857	0.000882	CcSEcCtD
Fenofibrate—Body temperature increased—Methotrexate—muscle cancer	0.000857	0.000882	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000855	0.00088	CcSEcCtD
Fenofibrate—Insomnia—Doxorubicin—muscle cancer	0.000849	0.000874	CcSEcCtD
Fenofibrate—Paraesthesia—Doxorubicin—muscle cancer	0.000843	0.000867	CcSEcCtD
Fenofibrate—Dyspnoea—Doxorubicin—muscle cancer	0.000837	0.000861	CcSEcCtD
Fenofibrate—Somnolence—Doxorubicin—muscle cancer	0.000835	0.000859	CcSEcCtD
Fenofibrate—Dyspepsia—Doxorubicin—muscle cancer	0.000826	0.00085	CcSEcCtD
Fenofibrate—Decreased appetite—Doxorubicin—muscle cancer	0.000816	0.00084	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000811	0.000834	CcSEcCtD
Fenofibrate—Fatigue—Doxorubicin—muscle cancer	0.000809	0.000833	CcSEcCtD
Fenofibrate—Pain—Doxorubicin—muscle cancer	0.000803	0.000826	CcSEcCtD
Fenofibrate—Constipation—Doxorubicin—muscle cancer	0.000803	0.000826	CcSEcCtD
Fenofibrate—Hypersensitivity—Methotrexate—muscle cancer	0.000799	0.000822	CcSEcCtD
Fenofibrate—Asthenia—Methotrexate—muscle cancer	0.000778	0.0008	CcSEcCtD
Fenofibrate—Feeling abnormal—Doxorubicin—muscle cancer	0.000774	0.000796	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000768	0.00079	CcSEcCtD
Fenofibrate—Pruritus—Methotrexate—muscle cancer	0.000767	0.000789	CcSEcCtD
Fenofibrate—Urticaria—Doxorubicin—muscle cancer	0.000746	0.000767	CcSEcCtD
Fenofibrate—Body temperature increased—Doxorubicin—muscle cancer	0.000742	0.000763	CcSEcCtD
Fenofibrate—Abdominal pain—Doxorubicin—muscle cancer	0.000742	0.000763	CcSEcCtD
Fenofibrate—Diarrhoea—Methotrexate—muscle cancer	0.000742	0.000763	CcSEcCtD
Fenofibrate—Dizziness—Methotrexate—muscle cancer	0.000717	0.000738	CcSEcCtD
Fenofibrate—Hypersensitivity—Doxorubicin—muscle cancer	0.000692	0.000712	CcSEcCtD
Fenofibrate—Vomiting—Methotrexate—muscle cancer	0.000689	0.000709	CcSEcCtD
Fenofibrate—Rash—Methotrexate—muscle cancer	0.000684	0.000703	CcSEcCtD
Fenofibrate—Dermatitis—Methotrexate—muscle cancer	0.000683	0.000703	CcSEcCtD
Fenofibrate—Headache—Methotrexate—muscle cancer	0.000679	0.000699	CcSEcCtD
Fenofibrate—Asthenia—Doxorubicin—muscle cancer	0.000674	0.000693	CcSEcCtD
Fenofibrate—Pruritus—Doxorubicin—muscle cancer	0.000664	0.000683	CcSEcCtD
Fenofibrate—Nausea—Methotrexate—muscle cancer	0.000644	0.000662	CcSEcCtD
Fenofibrate—Diarrhoea—Doxorubicin—muscle cancer	0.000642	0.000661	CcSEcCtD
Fenofibrate—Dizziness—Doxorubicin—muscle cancer	0.000621	0.000639	CcSEcCtD
Fenofibrate—Vomiting—Doxorubicin—muscle cancer	0.000597	0.000614	CcSEcCtD
Fenofibrate—Rash—Doxorubicin—muscle cancer	0.000592	0.000609	CcSEcCtD
Fenofibrate—Dermatitis—Doxorubicin—muscle cancer	0.000591	0.000608	CcSEcCtD
Fenofibrate—Headache—Doxorubicin—muscle cancer	0.000588	0.000605	CcSEcCtD
Fenofibrate—Nausea—Doxorubicin—muscle cancer	0.000558	0.000574	CcSEcCtD
